BCAL Diagnostics Limited (AU:BDX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
BCAL Diagnostics Limited announces the quotation of 3 million fully paid ordinary shares on the Australian Securities Exchange (ASX), following shareholder approval at the recent Annual General Meeting. This move marks a significant step for the company, potentially attracting investor interest and impacting stock market dynamics.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue